Albumin >= 2.5 g/dL within 30 days of day 1 of study
Within 2 weeks prior to registration: Serum albumin >= 2.8 g/dL
Serum albumin >= 3.0 g/dL within 90 days prior to Step 1 registration
Albumin >= 3.0 g/dL within 14 days of starting cycle 1 day 1 treatment
Obtained =< 2 weeks prior to registration: Albumin >= 3.0 g/dL
Serum albumin >= 3.0 g/dL performed within 30 days prior to the date of registration
Within 14 days of treatment registration: Albumin >= 2.5 mg/dL
Albumin >= 2 g/dL and documented within 14 days prior to registration and within 14 days prior to the start of treatment
Documented within 14 days of registration: Albumin >= 3 g/dL
Within 28 days prior to treatment start: Albumin >= 3.0 g/dL
Within 5 days prior to the start of study treatment: Albumin: >= 2.5 mg/dL.
Albumin >= 3 g/dL, within 14 days of registration and within 7 days of the start of treatment
Within 3 days before the first dose of study drug: albumin > 2.7 g/dL
Albumin >= 3.5 g/dL, obtained within 7 days prior to first study treatment
Obtained =< 14 days prior to registration: Albumin >= 2.5 mg/dL
Within 10 days prior to on-study date: Albumin ? 2.5 mg/dL
Obtained with 21 days of registration: albumin: > 2.8 g/dl
Within 7 days (+ 3 day window) of enrollment: Albumin >= 2.5 g/dl
Within 7 days before the first dose of study treatment: Serum albumin >= 2.8 g/dl
Obtained =< 28 days prior to registration: Albumin >= 2.5 mg/dL
Within 14 days prior to registration: Albumin >= 2.5 g/dL
Within 14 days prior to cycle 1 day 1 of treatment: Serum albumin >= 2.5 g/dL
Albumin >= 3.0 g/dL obtained < 4 weeks prior to starting treatment
Serum albumin >= 2 g/dL within 14 days of registration
Albumin > 2.5 g/dL (obtained within 28 days prior to first study treatment)
Serum albumin >= 2 g/dL within 7 days prior to enrollment
Albumin >= 2.0 g/dL or >= 20 g/L obtained =< 2 weeks prior to enrollment
Albumin > 2.7 g/dL (repeat if more than 3 days before the first dose)
Within 14 days prior to first dose of study drug treatment: Albumin >= 2.5 g/dL
Liver function tests performed within 3 weeks prior to starting study therapy must have albumin >= 2.5 g/dL
Within 7 days prior to study registration: Serum albumin >= 2 g/dL
Within 28 days of study registration: Albumin >= 3.0 g/dL
Patients must have albumin, urinalysis, and Troponin I obtained within 7 days prior to sub-study registration
Patients must have albumin, urinalysis, and Troponin I obtained within 7 days prior to substudy registration
Serum albumin > 3.0 g/dl within 14 days prior to registration
Within 14 days prior to registration: Serum albumin >= 3.0 g/dL
Serum albumin >= 2.5 g/dL, obtained within 14 days prior to initiation of study treatment
Albumin > 2.7 g/dL (repeat if more than 7 days before the first dose)
Patients must have a serum albumin >= 2.5 g/dL within 28 days prior to registration
Within 14 days prior to first study treatment: Albumin >= 3.5 g/dL
Albumin >= 2.5 g/dL within 28 days prior to registration
Albumin >= 3.0 g/dL, obtained within 14 days of the first dose of study drug
Obtained within 28 days prior to registration: Albumin > 2.5 g/dL
Albumin >= 2.5 mg/dL, obtained within 14 days prior to C11-AMT PET scan
Albumin < 3 g/dl obtained < 2 weeks prior to study enrollment
Albumin >= 2.5 mg/dL, obtained =< 30 days prior to registration
